Position in ALVO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$110,305
-$295,615 QoQ
Shares Held
32,159
-5.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $55,176,557 across 18 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
150,033 | $16,644,661 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
446,179 | $10,980,465 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
744,917 | $7,449,170 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
256,843 | $4,445,952 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
32,838 | $2,718,329 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
33,017 | $2,111,437 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
49,984 | $2,050,843 | |
| 8 | ALKS |
Alkermes plc.
|
31,684 | $1,660,241 |
All Filings in ALVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,305 | 32,159 | Shares | Sole | 2026-05-14 | |
| 2024-09-30 | $405,920 | 34,111 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||